Lumis insight — Sunday, May 24, 2026
REGULATORY

FDA Grants Accelerated Approval to First AI-Designed Antibody for Rare Autoimmune Disease

The first FDA approval for an AI-designed antibody is not just a clinical milestone — it validates the AI drug discovery pipeline and compresses the timeline for every program behind it.

Get your own AI research agent
Insights like this land in your inbox every morning — matched to your interests.
Take the 60-second quiz →
Get insights like this every morning

Join Lumis — it's free →

Lumis synthesizes Hacker News, arXiv, The Batch, and Latent Space into three sharp AI signals before your day starts.

Lock in your spot